Topiramate Tablet, Film Coated
Product Images NDC 51655-746

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 51655-746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)
Chemical structure of topiramate, depicting the arrangement of atoms and bonds within the molecule.*
FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)
A line graph showing cumulative rates for time to first seizure in patients treated with topiramate at 50 mg/day (solid line) and 400 mg/day (dashed line) over a 500-day period. The x-axis represents time in days, and the y-axis shows cumulative rates. The graph includes sample sizes (N = 234 for 50 mg/day and N = 236 for 400 mg/day) and a p-value of 0.0002.*
FDA Label Image

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)
A bar graph comparing the change from baseline to double-blind phase in average monthly migraine period rate for topiramate tablets at doses of 50 mg/day, 100 mg/day, and 200 mg/day versus placebo. Data from two studies (Study 11 and Study 12) are shown with group sizes noted. The graph includes significance markers indicating statistical differences at p<0.010 and p<0.001 levels.*
FDA Label Image

Label (51655 746 26)

Label (51655 746 26)
Label for Topiramate Tablets USP 50 mg, 90 tablets, oral film-coated tablets from Northwind Health Company, LLC. The label includes storage instructions, barcode, and batch information, including NDC 51655-746-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.